Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.

Goralczyk AD, Bari N, Abu-Ajaj W, Lorf T, Ramadori G, Friede T, Obed A.

Am J Transplant. 2012 Oct;12(10):2601-7. doi: 10.1111/j.1600-6143.2012.04157.x. Epub 2012 Jul 19. Review.

PMID:
22813081
[PubMed - indexed for MEDLINE]
Free Article
2.

Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.

Moore J, Middleton L, Cockwell P, Adu D, Ball S, Little MA, Ready A, Wheatley K, Borrows R.

Transplantation. 2009 Feb 27;87(4):591-605. doi: 10.1097/TP.0b013e318195a421. Review.

PMID:
19307799
[PubMed - indexed for MEDLINE]
3.

Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.

Herlenius G, Felldin M, Nordén G, Olausson M, Bäckman L, Gustafsson B, Friman S.

Transplant Proc. 2010 Dec;42(10):4441-8. doi: 10.1016/j.transproceed.2010.09.113.

PMID:
21168715
[PubMed - indexed for MEDLINE]
4.

Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress.

Grinyó JM, Cruzado JM.

Am J Transplant. 2009 Nov;9(11):2447-52. doi: 10.1111/j.1600-6143.2009.02812.x. Epub 2009 Sep 22. Review.

PMID:
19775321
[PubMed - indexed for MEDLINE]
Free Article
5.

Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.

Groetzner J, Kaczmarek I, Schulz U, Stegemann E, Kaiser K, Wittwer T, Schirmer J, Voss M, Strauch J, Wahlers T, Sohn HY, Wagner F, Tenderich G, Stempfle HU, Mueller-Ehmsen J, Schmid C, Vogeser M, Koch KC, Reichenspurner H, Daebritz S, Meiser B, Reichart B; VENINAHTx-Investigators.

Transplantation. 2009 Mar 15;87(5):726-33. doi: 10.1097/TP.0b013e3181963371. Erratum in: Transplantation. 2009 Apr 27;87(8):1264.

PMID:
19295318
[PubMed - indexed for MEDLINE]
6.

Calcineurin inhibitor minimization protocols in liver transplantation.

Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ.

Transpl Int. 2009 Jan;22(1):49-60. doi: 10.1111/j.1432-2277.2008.00796.x. Review.

PMID:
19121146
[PubMed - indexed for MEDLINE]
7.

Calcineurin-inhibitor-sparing immunosuppressive protocols.

Bestard O, Cruzado JM, Grinyó JM.

Transplant Proc. 2005 Nov;37(9):3729-32. Review.

PMID:
16386520
[PubMed - indexed for MEDLINE]
8.

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

Schlitt HJ, Barkmann A, Böker KH, Schmidt HH, Emmanouilidis N, Rosenau J, Bahr MJ, Tusch G, Manns MP, Nashan B, Klempnauer J.

Lancet. 2001 Feb 24;357(9256):587-91.

PMID:
11558484
[PubMed - indexed for MEDLINE]
9.

Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.

Flechner SM, Kobashigawa J, Klintmalm G.

Clin Transplant. 2008 Jan-Feb;22(1):1-15. doi: 10.1111/j.1399-0012.2007.00739.x. Review.

PMID:
18217899
[PubMed - indexed for MEDLINE]
10.

Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

Höcker B, Tönshoff B.

Paediatr Drugs. 2011 Feb 1;13(1):49-69. doi: 10.2165/11538530-000000000-00000. Review.

PMID:
21162600
[PubMed - indexed for MEDLINE]
11.

Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.

Flechner SM, Goldfarb D, Solez K, Modlin CS, Mastroianni B, Savas K, Babineau D, Kurian S, Salomon D, Novick AC, Cook DJ.

Transplantation. 2007 Apr 15;83(7):883-92.

PMID:
17460558
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M.

Ther Drug Monit. 2009 Apr;31(2):205-10. doi: 10.1097/FTD.0b013e31819743d9.

PMID:
19307937
[PubMed - indexed for MEDLINE]
13.

Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.

Tönshoff B, Höcker B.

Pediatr Transplant. 2006 Sep;10(6):721-9. Review.

PMID:
16911497
[PubMed - indexed for MEDLINE]
14.

Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring.

Cicinnati VR, Yu Z, Klein CG, Sotiropoulos GC, Saner F, Malagó M, Frilling A, Gerken G, Broelsch CE, Beckebaum S.

Aliment Pharmacol Ther. 2007 Nov 1;26(9):1195-208.

PMID:
17944734
[PubMed - indexed for MEDLINE]
Free Article
15.

Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction.

Kornberg A, Küpper B, Thrum K, Krause B, Büchler P, Kornberg J, Sappler A, Altendorf-Hofmann A, Wilberg J, Friess H.

Dig Dis Sci. 2011 Jan;56(1):244-51. doi: 10.1007/s10620-010-1386-z. Epub 2010 Sep 8.

PMID:
20824504
[PubMed - indexed for MEDLINE]
16.

Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.

Raimondo ML, Dagher L, Papatheodoridis GV, Rolando N, Patch DW, Davidson BR, Rolles K, Burroughs AK.

Transplantation. 2003 Jan 27;75(2):186-90.

PMID:
12548120
[PubMed - indexed for MEDLINE]
17.

Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study.

Beckebaum S, Cicinnati VR, Klein CG, Brokalaki E, Yu Z, Malago M, Frilling A, Gerken G, Broelsch CE.

Transplant Proc. 2004 Nov;36(9):2671-4.

PMID:
15621120
[PubMed - indexed for MEDLINE]
18.

Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation.

Gerhardt T, Terjung B, Knipper P, Palmedo H, Woitas RP, Kalff J, Sauerbruch T, Spengler U.

Eur J Med Res. 2009 May 14;14(5):210-5.

PMID:
19541578
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.

Ponton C, Vizcaíno L, Tomé S, Otero E, Molina E, Castroagudín JF, López-Lago A, Varo Pérez E.

Transplant Proc. 2010 Mar;42(2):656-9. doi: 10.1016/j.transproceed.2010.02.006.

PMID:
20304216
[PubMed - indexed for MEDLINE]
20.

Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.

Pageaux GP, Rostaing L, Calmus Y, Duvoux C, Vanlemmens C, Hardgwissen J, Bernard PH, Barbotte E, Vercambre L, Bismuth M, Puche P, Navarro F, Larrey D.

Liver Transpl. 2006 Dec;12(12):1755-60.

PMID:
17133564
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk